TIMP1 and colorectal cancer: Our rigorous inquiry revealed a compelling discovery: colorectal cancer cell lines with elevated TIMP1 expression exhibited significantly increased responsiveness to a selection of ten distinct pharmacological agents (log2FC < −1).